Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: OECD Guideline Study under GLP, only one experiment performed, but clearly negative result

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
only one experiment performed
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Esterification products of glycerol with docosanoic acid, icosanedioic acid and 16-methylheptadecanoic acid
EC Number:
942-166-5
Cas Number:
922708-02-9
Molecular formula:
not applicable
IUPAC Name:
Esterification products of glycerol with docosanoic acid, icosanedioic acid and 16-methylheptadecanoic acid
Test material form:
not specified
Details on test material:
- Name of test material (as cited in study report): Nomcort SG
- Substance type: not stated
- Physical state: not stated
- Analytical purity: not stated
- Lot/batch No.: P070214
- Expiration date of the lot/batch: not stated
- Stability under test conditions: not stated
- Storage condition of test material: room temperature

Method

Target gene:
Histidine, Trypthophan
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
rat Liver S9 mix
Test concentrations with justification for top dose:
0.05, 0.1, 0.5, 1.0, 5.0 mg/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: The test item was found to be completely soluble in the vehicle.
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
2-nitrofluorene
sodium azide
methylmethanesulfonate
other: 2-Aminoanthracene, 6-Chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation);

DURATION
- Exposure duration / Expression time): 48 h

NUMBER OF REPLICATIONS: 3
Evaluation criteria:
according to Guideline (OECD 471)
Statistics:
calculation of Average and standard deviation, no further statistics performed

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Additional information on results:
no further remarks
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

There was no detectable genotoxic activity or cytotoxicity for Nomcort SG under the conditions of the test.
Executive summary:

The genetic toxicity in bacteria was tested using the method by Ames laid down in OECD Guideline 471. Five strains of bacteria were tested (Salmonella typhimurium 98, 100, 1535, 1537 and Escherichia Coli WP2 uvrA) using a plate incorporation protocol. Nomcort SG was tested in the concentrations 0.05, 0.1, 0.5, 1.0 and 5.0 mg/plate with Acetone as solvent. Additionally positive and solvent control were tested. Metabolic activation was included using rat S9 -liver fraction.

All concentrations, positive and solvent control were tested in triplicate.

Solvent control and positive control were evaluated valid and within the historic data. No concentration of Nomcort SG with or without metabolic activation yielded in an increased mutagenic response, as well as no cytotoxicity was noted.

Nomcort SG was evaluated as NOT MUTAGENIC under the conditions of the test.